During Thursday’s trade, Shares of Facebook Inc (NASDAQ:FB), gain 1.10% to $105.73, after a company executive said that Facebook at Work, the professional version of the company’s social network, is predictable to launch in the coming months, according to Reuters.
“I would say 95 percent of what we developed for Facebook is also adopted for Facebook at Work,” Julien Codorniou, director of global platform partnerships at Facebook, told Reuters.
However, the company is also developing exclusive products for the venture, counting security tools and special profiles that are distinct from user’s current profiles.
Facebook has been beta-testing Facebook at Work since January as a free, invite-only service for over 300 companies so far.
Facebook will charge “a few dollars per month per user” for premium services on the platform, a company spokeswoman told Reuters.
On the other news report, Facebook artificial intelligence, or AI, research unit has already open-sourced most of its code and research. Now for the first time, Facebook is sharing its own AI hardware design, according to Forbes
The Menlo Park, Calif.-based company is open-sourcing the design of its newest server for large-scale artificial intelligence (AI) computing, which it plans to submit to the Open Compute Project, which shares designs of data center products among a number of large companies. The server, called “Big Sur,” incorporates graphics processing units, or GPUs, the horsepower for handling large data sets. Big Sur is built for training neural networks, key to nearly any type of modern AI research, for example, projects related to language, text or video. The company said the move is noteworthy because more powerful computers, especially those powered by GPUs, have been critical to most of the recent noteworthy advances in machine learning and AI.
Facebook said it has a culture of support for open-source hardware and software and that it has benefited from hardware designs other companies have shared with Open Compute. A company spokesperson said the design could benefit startups or academics who need to build AI hardware, but who lack Facebook’s resources. The company also said it is more than tripling its investment in GPU hardware and is increasingly focusing on research as Facebook uses AI more broadly across its services. The social media giant’s decision to share Big Sur is predictable to set a precedent of Facebook open-sourcing more AI hardware in the future, a company spokesperson said. Facebook has been testing Big Sur in its labs, but still also uses its previous version of the hardware, the spokesperson said. Facebook built Big Sur with Quanta and Nvidia. Forbes Report
Facebook, Inc. is a social networking company. The Company is engaged in developing products that enables users to connect and share through mobile devices and personal computers. It offers various services focused on people, marketers and developers.
Shares of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), declined -3.34% to $4.63, during its current trading session.
On December 9, Aeterna Zentaris Inc. (AEZS) declared the pricing of its formerly declared underwritten public offering (the “Offering”) of common shares and warrants with a public offering price of US$5.55 for one common share together with a warrant to purchase 0.7 of a common share for gross proceeds of US$16.65 million. A total of 3.0 million common shares and warrants to acquire 2.1 million common shares are predictable to be issued on closing of the Offering. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 330,000 common shares and/or warrants to purchase up to an additional 231,000 common shares, to cover over-allotments, if any.
The warrants will be exercisable right away and expire five years following issuance at an exercise price of US$7.10 per share. The warrants do not contain any price or other adjustment provision, except for customary adjustment provisions that apply in the event of certain corporate events or transactions that affect all outstanding common shares. The warrants may at any time be exercised on a “net” or “cashless” basis in accordance with a customary formula but do not contain an alternate cashless exercise feature contained in our formerly issued Series B common shares purchase warrants. The warrants will not be listed on any stock exchange.
The Offering is predictable to close on or about December 14, 2015, subject to customary closing conditions counting, but not limited to, the receipt of all necessary regulatory approvals, counting the approvals of the NASDAQ Capital Market (“NASDAQ”) and the Toronto Stock Exchange (“TSX”).
On the other news report, on December 8, Aeterna Zentaris Inc. declared that it has commenced an underwritten public offering (the “Offering”) of common shares and warrants to purchase common shares. Investors whose purchase of common shares in the Offering would result in them beneficially owning more than the initial beneficial ownership limitation to be comprised in the warrants following the consummation of the Offering will have the opportunity to acquire pre-funded warrants substituted for any common shares they would have otherwise attained over the initial beneficial ownership limitation, paying the same price per share. The pricing and number of shares and warrants in addition to the exercise price and duration of the warrants will be determined in the course of marketing.
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company engaged in developing treatments in oncology, endocrinology and women’s health. The Company has three wholly owned direct and indirect auxiliaries: AEZS GmbH, based in Frankfurt, Germany, Zentaris IVF GmbH, a direct wholly owned partner of AEZS Germany based in Frankfurt, Germany, and Aeterna Zentaris, Inc. Its drug development efforts are focused on two compounds, zoptarelin doxorubicin and Macrilen, which are in clinical development, and on two oncology compounds (an Erk inhibitor and Luteinizing Hormone-Releasing Hormone-disorazol Z product candidates), which are in pre-clinical development.
Finally, Shares of Exxon Mobil Corporation (NYSE:XOM), gain 0.97%, and is now trading at $76.38.
On December 8, Rex W. Tillerson, chairman and chief executive officer of Exxon Mobil Corporation (XOM), presented Jonathan’s Place with the company’s annual holiday gift of $50,000, advancing the nonprofit agency’s mission of providing housing and specialized services to abused, abandoned and neglected children from newborns through adolescence. ExxonMobil’s donation kicks off the agency’s 25th anniversary year, during which it will celebrate its long-standing commitment to North Texas children.
“Jonathan’s Place provides critical life-saving support services to those who are most vulnerable during times of crisis,” Tillerson said. “ExxonMobil is proud to support its mission and celebrate its dedication to North Texas children for more than a quarter of a century.”
Established in 1991 as the first licensed foster group home for drug-addicted infants and small children in Texas, Jonathan’s Place remains the only licensed emergency shelter in Dallas County serving children in crisis under the age of 5. In addition to serving clients through its emergency shelter, the organization advocates for foster care and adoption, and has an extensive program to support families who open their homes and hearts to children in need. Five years ago, its services expanded to offer a program providing a therapeutic approach to overcoming the traumatic effects of physical and mental abuse, specifically for girls in the child welfare system.
ExxonMobil established the holiday gift in 2006 to support North Texas nonprofit agencies during the holiday season. Past recipients comprise ACH Child and Family Services, Children’s Advocacy Center of Denton County, Grapevine Relief and Community Exchange (GRACE), Interfaith Housing Coalition, Irving Cares, Lena Pope Home, Presbyterian Night Shelter of Tarrant County, St. Philip’s School and Community Center, and Vogel Alcove.
Exxon Mobil Corporation is an energy company. The Company is engaged in the exploration and production of crude oil and natural gas. The Company is involved in the manufacturing of petroleum products, and transportation and sale of crude oil, natural gas and petroleum products. The Company also manufactures and markets petrochemicals, counting olefins, aromatics, polyethylene and polypropylene plastics, and a variety of specialty products.